M. Kumari, B. Rathi, and G. Singh, “Epicatechin as a potential hit to target ERK2 in breast cancer: molecular docking, molecular dynamic simulation studies”, J Integr Sci Technol, vol. 13, no. 4, p. 1074, Jan. 2025, doi: 10.62110/sciencein.jist.2025.v13.1074.